Stock Markets: Nasdaq

Catena Media resolves upon a directed new issue of shares as payment for assets signed in May 2017 as well as in June 2018

Thu, Jul 19, 2018 17:30 CET The Board of Directors of Catena Media plc (“Catena Media” or the “Company”) has, under the authorization conveyed by the Company’s Articles of Association and in accordance with press releases issued on 23 May, 2017 and 13 June, 2018, resolved to implement a directed new share issue of a total 271,722 shares. On 23 May, 2017, the Company announced that it had signed New Casinos Ltd., including related affiliate assets, and that at most 50 percent of the maximum...

Published on .

Alligator Bioscience submits application to start clinical phase I study in cancer patients with ATOR-1015, a unique CTLA-4 and OX40 binding antibody

Thu, Jul 19, 2018 16:11 CET Lund, Sweden, July 19, 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today announced that the company has submitted a clinical trial authorization (CTA) application to the relevant regulatory authorities to start a phase I study of its wholly-owned bispecific drug candidate ATOR-1015. The upcoming phase I study with ATOR-1015 is a first-in-human dose escalation...

Published on .

Probi CFO to resign

Thu, Jul 19, 2018 15:30 CET Probi AB (publ) (“Probi”) announces that Jörn Andreas will leave his position as CFO tentatively as per 31 December 2018, or such earlier or later date when a new CFO can take office. The request to leave is made for personal reasons. “Jörn Andreas has been a highly appreciated and valued member of group management and, previously, board member of Probi. We regret that he has decided to move back to Germany”, says chairman of the board Jean-Yves Parisot. The...

Published on .

MTG notes the decision by the Bulgarian Commission for Protection of Competition

Thu, Jul 19, 2018 15:20 CET MTG notes today’s decision by the Bulgarian Commission for Protection of Competition to disallow the proposed sale, announced on 19 February, of MTG’s shareholding in Nova Broadcasting Group in Bulgaria to PPF Group. MTG is surprised by the decision and will review it further before deciding on the next steps to be taken. ****  NOTES TO EDITORS MTG (Modern Times Group MTG AB (publ)) is a leading international digital entertainment group and we are shaping the...

Published on .

Very strong quarter for all business areas

Thu, Jul 19, 2018 14:30 CET Today’s report by Nolato for the second quarter of 2018 shows a continued very strong performance. Sales increased to SEK 2,302 million (1,675) Operating profit (EBITA) rose to SEK 266 million (178) The EBITA margin was 11.6% (10.6) Profit after tax was SEK 204 million (131) Basic earnings per share increased to SEK 7.75 (4.98) Cash flow after investments was SEK 352 million (28) Sustained strong financial position Adjusted for currency, sales for the Group increased...

Published on .

Interim report, January – June 2018: Strong order intake and increased growth

Thu, Jul 19, 2018 13:00 CET “Ework continued to progress as planned in the second quarter. Again, sales and order intake were in healthy growth, and our EBIT improved year on year. Growth is still being driven by very high client demand. We have reached the final stage of an investment phase that we expect to make a progressive positive contribution to our earnings performance.” Extract from CEO Zoran Covic’s commentary to the Interim report. Second quarter 2018 compared to 2017 Net sales...

Published on .

Harding and Company – IPO Market – 2nd Half of 2018 Preview

Top IPO's for 2018 Harding and Company looks at what is in store for the remainder of the 2018 IPO Calendar, highlighting the major players looking to list by the end of the year. NEW YORK, NEW YORK, UNITED STATES, July 18, 2018 -- The first half of 2018’s IPO market saw several heavy hitters list. Most notably were Spotify, Dropbox and Xiaomi who were instrumental in seeing a 5% increase over 2017’s figures for the same period despite fewer companies coming to market.Spotify...

Published on .

Evolus, Inc. Announces Pricing of Public Offering of Common Stock

IRVINE, Calif., July 18, 2018 -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today the pricing of its public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per share, before underwriting discounts and commissions.  The offering consists of 3,000,000 shares offered by Evolus and 1,000,000 shares offered by a selling stockholder of Evolus, resulting in aggregate net proceeds of approximately $56.4 million to Evolus and approximately $18.8 million to the...

Published on .

Establishment Labs Announces Pricing of Initial Public Offering

NEW YORK, July 18, 2018 -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing of its initial public offering of 3,715,277 common shares at a public offering price of $18.00 per share.  All of the common shares are being offered by Establishment Labs.  In addition, Establishment Labs has granted the underwriters a 30-day option to purchase up to 557,291 additional common...

Published on .

Scoping Study Delivers Outstanding Results

NEW YORK, July 18, 2018 -- Piedmont Lithium Limited (“Piedmont” or “Company”) (ASX:PLL) (NASDAQ:PLLL) is pleased to report the results of the Company’s Scoping Study for its vertically-integrated Piedmont Lithium Project (“Project”) located within the Carolina Tin-Spodumene Belt in North Carolina, USA (“TSB”).  The Project includes a lithium hydroxide chemical plant (“Chemical Plant”) supplied with spodumene concentrate from an open pit mine and concentrator (“Mine/Concentrator”).The...

Published on .

Carbonite Announces Pricing of Public Offering of Common Stock

BOSTON, July 18, 2018 -- Carbonite, Inc. (NASDAQ:CARB), a leader in data protection, today announced the pricing of an underwritten public offering of  4,765,157 shares of its common stock at the public offering price of $37.50 per share.  In addition, 698,080 shares beneficially owned by David Friend, a co-founder and director, have been offered by a selling stockholder at the public offering price.  Carbonite has granted the underwriters a 30-day option to purchase up to an additional...

Published on .

Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock

STAMFORD, Conn., July 18, 2018 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting kappa opioid receptors, today announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $19.00 per share. The offering is expected to close on or about July 23, 2018, subject to...

Published on .

VivoPower International PLC Reports Results for the Year Ended March 31, 2018

LONDON, July 18, 2018 -- VivoPower International, PLC (NASDAQ:VVPR) (“VivoPower”) an international solar power producer and storage company, today announced its financial results for the year ended March 31, 2018.“Fiscal 2018 was a challenging year for VivoPower,” said Carl Weatherley-White, VivoPower’s Chief Executive Officer. “Over the last six months, VivoPower has executed a strategic shift to prioritise solar development in the United States and Australia. Importantly, we have focused...

Published on .

AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares

Lausanne, Switzerland, July 19, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the price per common share of USD 11.75 for the offerings of up to 10 million new common shares of the Company. The offering price will be the same for all three offerings, the details of which were published yesterday, namely:The first subscription rights offering;The primary offering; andThe second subscription rights...

Published on .